VYNE Therapeutics’ mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Location: United States, New Jersey, Bridgewater
Employees: 51-200
Founded date: 2003
Investors 3
| Date | Name | Website |
| 27.11.2023 | Access Bio... | accessbio-... |
| - | Perceptive... | perceptive... |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 19.01.2022 | VYNE THERAPEUTICS INC. : Other Events, Financial Statements ... | Item 8.01 Other Events. On January 19, 2022, VYNE Therapeutics Inc. (the "Company") issued... | marketscre... |
| 21.10.2021 | VYNE Therapeutics : Announces Formation of Scientific Adviso... | Renowned Experts to Support VYNE’s Strategy of Developing Novel Treatments for Immunological and Inf... | marketscre... |
| 30.03.2021 | VYNE THERAPEUTICS INC. VYNE Therapeutics : Investor Relatio... | INVESTOR PRESENTATION March 2021 Forward Looking Statements This presentation includes forward-looki... | marketscre... |
| 07.10.2020 | VYNE Therapeutics Announces Covered Status for ZILXI™ (minoc... | prnewswire... | |
| 01.10.2020 | VYNE Therapeutics Announces ZILXI™ (minocycline) topical foa... | prnewswire... |